文献速递肾小球疾病遗传性与小管间质肾病

补体在IgA肾病微血管病变中的作用

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy.
PubMed 文献 · Kidney Int Rep · 2022-04-04

本研究通过免疫组化检测IgA肾病患者小动脉补体沉积,并用ELISA和全外显子测序探索机制,发现伴微血管病变(MA)患者小动脉补体沉积(尤其C4d)更多,且Gd-IgA1和C3a水平更高,近半数MA患者存在补体相关基因罕见变异。

要点

  • 伴MA病变的IgA肾病患者小动脉C4d沉积比例(100%)高于动脉硬化(53%)和无血管病变(14%)患者,P<0.05。
  • 伴MA病变患者Gd-IgA1中位数326.98 U/ml,高于动脉硬化组319.22和无血管病变组321.95,P=0.014。
  • 伴MA病变患者C3a为122.57±42.07 ng/ml,高于动脉硬化组93.79±29.49和无血管病变组93.51±45.87,P=0.01。

核心结论

  • 补体参与IgA肾病MA病变的发生,可能与含Gd-IgA1的循环复合物有关。

研究设计与样本

  • 采用免疫组化检测小动脉补体沉积,并用ELISA和全外显子测序探索机制,包含一个大型前瞻性队列。

主要发现

  • 伴MA病变的IgA肾病患者小动脉补体沉积(尤其C4d)比例100%,高于动脉硬化组53%和无血管病变组14%,P<0.05。
  • 伴MA病变患者Gd-IgA1中位数326.98 U/ml(四分位距303.46-370.5),高于动脉硬化组319.22(292.01-347.3)和无血管病变组321.95(291.68-350.68),P=0.014。
  • 伴MA病变患者C3a为122.57±42.07 ng/ml,高于动脉硬化组93.79±29.49和无血管病变组93.51±45.87 ng/ml,P=0.01。
  • 血清IgA1和C3水平在三组间无显著差异。
  • 全外显子测序发现近半数MA病变患者存在补体相关基因的罕见变异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Arteriolar microangiopathic (MA) lesions are independent risk factors for IgA nephropathy (IgAN) patient prognosis, and the underlying mechanism remains to be elucidated. The complement plays an important role in IgAN and thrombotic microangiopathy; however, its role in MA lesions in IgAN remains unclear. METHODS: Immunohistochemistry was performed to detect arteriolar complement deposition. Enzyme-linked immunosorbent assay (ELISA) and whole-exome sequencing were performed to explore possible mechanism. RESULTS: In this study, we found that patients with IgAN with MA lesions have more complement deposition, especially C4d, on renal arterioles than those in patients with arteriolosclerosis (AS) and patients with no vascular lesions (100% vs. 53% vs. 14%, P < 0.05). Furthermore, our large prospective cohort demonstrated that patients with IgAN with MA lesions had higher levels of Gd-IgA1 (median: 326.98 U/ml, interquartile range 303.46-370.5 vs. 319.22, 292.01-347.3 vs. 321.95, 291.68-350.68, P = 0.014) and C3a (122.57 ± 42.07 vs. 93.79 ± 29.49 vs. 93.51 ± 45.87 ng/ml, P = 0.01) than those in patients with AS and those with no vascular lesions. However, serum IgA1 and C3 levels were not significantly different. Finally, through whole-exome sequencing, we found that nearly half of the patients with MA lesions had rare genetic variations in complement-related genes. CONCLUSION: Our results indicate that the complement is involved in the development of MA lesions in IgAN, which might be associated with the circulating complex containing Gd-IgA1.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Li J, Guo L, Shi S, et al. The Role of Complement in Microangiopathic Lesions of IgA Nephropathy. Kidney Int Rep. 2022. PMID: 35685318. doi:10.1016/j.ekir.2022.03.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。